Daniel Campbell’s Post

A new rule posted on the Office of Management and Budget (OMB) registry suggests that the Drug Enforcement Administration (DEA) is planning an additional extension of COVID-19 flexibilities for telemedicine prescribing of controlled substances, beyond the current expiration date of December 31, 2024. Read up on key implications for stakeholders here: https://lnkd.in/gPXhcxmV

The DOJ has recently updated its ECCP guidance, emphasizing risk assessment, compliance empowerment, and continuous improvement. Join my colleagues for a comprehensive webinar where they'll discuss these changes and their implications for corporate compliance. Learn practical strategies to enhance your compliance programs and navigate DOJ expectations effectively. Register today! https://lnkd.in/gBhndfJf

My colleagues are both speaking at the upcoming ABA/ABA Financial Crimes Enforcement Conference 2024. Their panel provides an update on the status of the FinCEN and DOJ whistleblower programs. Learn more: https://lnkd.in/gVFackK6

On September 23, the DOJ revised its corporate compliance guidance, focusing on AI risks, data resources, and a speak-up culture. These changes highlight the DOJ’s expectations for corporate compliance. Unpack the details in our recent On the Subject: https://lnkd.in/gqM-dwBD

Fresh off of arguing its first two hearings before the #UnifiedPatentCourt in Paris, McDermott's #UPC team shares key developments from the new court in our latest newsletter. This issue examines a recent decision highlighting a difference in rules governing access to confidential information in the UPC compared to US courts, as well as the impact of varying approaches to case management across the UPC. Read more: https://lnkd.in/d4DNdcJW

The agenda is LIVE for Health Lit Forum 2024 and full of reasons not to miss this year’s program. We’re bringing together industry leaders from top healthcare providers, payors and life sciences companies to share the latest regulatory and enforcement trends, their implications, and effective management strategies. The entire program is complimentary. Space in our in-person program is limited, so save your spot today! https://lnkd.in/gjwzC4P8

Our employees have spoken! Our company culture is amazing and our Great Place To Work Certification proves it! 🎉 A big thank you to our incredible clients and dedicated team for continuously driving us to be #AlwaysBetter. Want to experience what it’s like to work at McDermott? Explore opportunities and apply today at careers.mwe.com.

My colleague Sarah Raaii was quoted in Modern Healthcare reacting to the White House’s final rule on mental health parity. "It’s a 'be careful what you wish for' situation for employers and health plans. They have been frustrated by the lack of agency guidance on exactly how to apply the mental health parity rules, so these final rules might shed some light on that, while creating additional obligations for employers and health plans." https://lnkd.in/gx84ERgi

Healthcare investors and providers, join my colleagues as they discuss new state and federal legal requirements impacting healthcare transactions. They’ll discuss recent legislation impacting the space, including California’s AB 3129, and proactive approaches to reduce potential transaction delays. Stay ahead of these requirements and register today: https://lnkd.in/grrvnr57

Check out the latest Alcohol Law Advisor article on seasonal considerations for packaging and selling alcoholic beverages. My colleagues dive into the TTB guidelines, discuss packaging limitations, and explore pricing strategies to help you navigate the seasonal market effectively. Read more: https://lnkd.in/g7aWC8NF